atai Life Sciences to Participate in the Canaccord Genuity 44th Annual Growth Conference
NEW YORK and BERLIN, Aug. 07, 2024 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced that the Company’s management team is scheduled to participate in the Canaccord Genuity 44th Annual Growth Conference taking place in Boston, MA from August 13-15, 2024. Details of the company’s participation:
ATAI LIFE SCIENCES NV
NASDAQ:ATAI (2/13/2025, 2:04:09 PM)
2.2299
-0.32 (-12.55%)
ATAI Latest News and Analysis
21 hours ago - ChartmillWondering what's happening in today's after-hours session?After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
